Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, randomized, placebo-controlled safety trial evaluating the effects of residual renal function in patients with end-stage renal disease a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Biogen | Conditions: End-Stage Renal Disease, Type 2 Diabetes Mellitus | Phase 2 | Status: WITHDRAWN